Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells

Fig. 1

Characterization of Chimeric HLA Accessory Receptor (CHAR). a Design of CHAR construct in retrovirus backbone. The Bridge spans the distance between B2M and the cell surface. The Q8 marker contains an epitope from CD34. b Schematic of HLA class I molecule (Left) and CHAR (Middle) forming a complex (Right). c Daudi cells were transduced with the CHAR construct and stained for expression of HLA class I molecules using a HLA-ABC antibody on Day 3. d CHAR transduced Daudi cells were stained for HLA-ABC and CD34 to identify the Q8 marker

Back to article page